ישראל - עברית - Ministry of Health

steba laboratories ltd., israel - padeliporfin dipotassium - אבקה להכנת תמיסה לאינפוזיה - padeliporfin dipotassium 200 mg

ישראל - עברית - Ministry of Health

steba laboratories ltd., israel - padeliporfin dipotassium - אבקה להכנת תמיסה לאינפוזיה - padeliporfin dipotassium 400 mg

ישראל - עברית - Ministry of Health

teva medical ltd. - migada - אחות - see attached document : us fda 510(k) k051669 approved indications for use

ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - erythromycin as stearate - טבליה - erythromycin as stearate 500 mg - erythromycin - erythromycin - treatment of the following infections when caused by susceptible organisms: upper and lower respiratory tract infections. skin and soft tissue infections. conjunctivitis of the newborn caused by chlamydia trachomatis. urogenital infections caused by chlamydia trachomatis. venereal diseases (as an alternative regimen to penicillins and tetracyclines). intestinal amebiasis. legionnaires' disease. long-term prophylaxis in rheumatic fever. short-term prophylaxis against bacterial endocarditis in patients hypersensitive to penicillin who have congenital heart disease or rheumatic or other acquired valvular heart disease when undergoing dental procedures and surgical procedures of the upper respiratory tract. enteric infections caused by campylobacter jejuni.

ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - erythromycin as stearate - טבליה - erythromycin as stearate 250 mg - erythromycin - erythromycin - treatment of the following infections when caused by susceptible organisms: upper and lower respiratory tract infections. skin and soft tissue infections. conjunctivitis of the newborn caused by chlamydia trachomatis. urogenital infections caused by chlamydia trachomatis. venereal diseases (as an alternative regimen to penicillins and tetracyclines). intestinal amebiasis. legionnaires' disease. long-term prophylaxis in rheumatic fever. short-term prophlaxis against bacterial endocarditis in patients hypersensitive to penicillin who have congenital heart disease or rheumatic or other acquired valvular heart disease when undergoing dental procedures and surgical procedures of the upper respiratory tract. enteric infections caused by campylobacter jejuni.

ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - erythromycin as stearate - טבליה - erythromycin as stearate 250 mg - erythromycin - erythromycin - treatment of the following infections when caused by susceptible organisms: upper and lower respiratory tract infections. skin and soft tissue infections. conjunctivitis of the newborn caused by chlamydia trachomatis. urogenital infections caused by chlamydia trachomatis. venereal diseases (as an alternative regimen to penicillins and tetracyclines). intestinal amebiasis. legionnaires' disease. long-term prophylaxis in rheumatic fever. short-term prophlaxis against bacterial endocarditis in patients hypersensitive to penicillin who have congenital heart disease or rheumatic or other acquired valvular heart disease when undergoing dental procedures and surgical procedures of the upper respiratory tract. enteric infections caused by campylobacter jejuni.

ישראל - עברית - Ministry of Health

teva pharmaceutical industries ltd, israel - erythromycin as stearate - טבליה - erythromycin as stearate 500 mg - erythromycin

ישראל - עברית - Ministry of Health

teva israel ltd - filgrastim - תמיסה להזרקה\אינפוזיה - filgrastim 0.6 mg/ml - filgrastim - filgrastim - tevagrastim is indicated for the reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with established cytotoxic chemotherapy for malignancy (with the exception of chronic myeloid leukaemia and myelodysplastic syndromes ) and for the reduction in the duration of neutropenia in patients undergoing myeloablative therapy followed by bone marrow transplantation considered to be at increased risk of prolonged severe neutropenia. the safety and efficacy of tevagrastim are similar in adults and children receiving cytotoxic chemotherapy. tevagrastim is indicated for the mobilisation of peripheral blood progenitor cells in normal donors (allogeneic pbpc). in patients children or adults with severe congenital neutropenia cyclic or idiopathic neutropenia with an absolute nuetrophil count (anc) less than or equal to 0.5 x 1000000000 /l and a history of severe or recurrent infections long term administration of tevagrastim is indicated to increase neutophil count and to red

ישראל - עברית - Ministry of Health

teva israel ltd - clotrimazole; dexamethasone acetate; neomycin sulfate - קרם - clotrimazole 1 %; dexamethasone acetate 0.044 %; neomycin sulfate 0.645 % - dexamethasone - dexamethasone - tevacutan is indicated for the treatment of mycotic infections of the skin complicated by inflammation and/or secondary infection.

ישראל - עברית - Ministry of Health

teva israel ltd - simvastatin - טבליה - simvastatin 20 mg - simvastatin - simvastatin - coronary heart disease : in patients with coronary heart disease and hypercholesterolemia simvastatin-teva is indicated to: - reduce the risk of total mortality by reducing coronary death - reduce the risk of non-fatal myocardial infarction - reduce the risk for undergoing myocardial revascularization procedures. - reduce the risk of stroke and transient ischemic attacks (tia). hyperlipidemia: simvastatin-teva is indicated as an adjunct to diet to reduce elevated total-c ldl-c apo b and tg and to increase hdl-c in patients with primary hypercholesterolemia (heterozygous familial and nonfamilial) and mixed dyslipidemia (frederickson types iia and iib) simvastatin-teva therefore lowers the ldl-c/hdl-c and the total-c/hdl-c ratios. homozygous familial hypercholesterolemia: simvastatin-teva is also indicated as an adjunct to diet and other non-dietary measures in reducing elevated total cholesterol ldl-cholesterol and apolipoprotein b in patients with homozygous familial hypercholesterolemia when response to thes